Live feed08:30:00·14mPRReleasevia QuantisnowMAIA Biotechnology Opens Enrollment for Phase 2 Expansion Trial of Novel Telomere-Targeting Agent at Winship Cancer Institute of Emory UniversityByQuantisnow·Wall Street's wire, on your screen.MAIA· MAIA Biotechnology Inc.Health Care
